We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01436903
First Posted: September 20, 2011
Last Update Posted: March 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Beda Hartmann, Medical University of Vienna
  Purpose
CavatermTM is a second-generation thermal balloon ablation device in the management of menorrhagia. The purpose of this study is to investigate the success (questionnaire) of CavatermTM dependent on uterus probe length, especially corpus probe length, which is measured during surgery.

Condition Intervention Phase
Menorrhagia Device: Thermal Balloon Endometrial Ablation Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length, a Questionnaire Investigation on 290 Patients

Further study details as provided by Beda Hartmann, Medical University of Vienna:

Primary Outcome Measures:
  • Postsurgical change in bleeding patterns dependent on cavum probe length. [ Time Frame: Corpus probe length will be measured during surgery, a questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    Success is defined as a-, hypo- or eumenorrhoea, regular cycle, reduction of dysmenorrhoea.

  • Postsurgical change in patient satisfaction dependent on cavum probe length. [ Time Frame: Corpus probe length will be measured during surgery, a questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    The questionnaire will ask for satisfaction and recommendation to the best friend.


Secondary Outcome Measures:
  • Postsurgical change in dyspareunia [ Time Frame: A questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    The questionnaire will ask for pre- and postsurgical dyspareunia.

  • Postsurgical change in Premenstrual Syndrome [ Time Frame: A questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    The questionnaire will ask for pre- and postsurgical Premestrual Syndrome.

  • Prevention of further gynaecological therapies [ Time Frame: A questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    The questionnaire will ask for postsurgical hysterectomy and further medications.

  • Improvement of quality of life [ Time Frame: A questionnaire will be sent in September 2010, at least after one postsurgical year. ]
    The questionnaire will ask for postsurgical quality of life.


Enrollment: 290
Study Start Date: September 2010
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Thermal Balloon Endometrial Ablation
    Thermal Balloon Endometrial Ablation for 10 minutes after curettage
    Other Name: CavatermTM
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • CavatermTM operation because of menorrhagia
  • timeframe: January 2006 till August 2009
  • older than 29 years and younger than 56 years

Exclusion Criteria:

  • pregnancy
  • fragmentary filled questionnaire
  • more than 1 CavatermTM operation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01436903


Locations
Austria
Landesklinikum Thermenregion Neunkirchen
Neunkirchen, Lower Austria, Austria, 2620
Sponsors and Collaborators
Medical University of Vienna
Investigators
Principal Investigator: Beda W. Hartmann, Univ.-Doz. Medical University of Vienna
  More Information

Responsible Party: Beda Hartmann, Univ.-Doz. Dr. Mag., Medical University of Vienna
ClinicalTrials.gov Identifier: NCT01436903     History of Changes
Other Study ID Numbers: 743/2010
First Submitted: August 12, 2011
First Posted: September 20, 2011
Last Update Posted: March 8, 2013
Last Verified: March 2013

Keywords provided by Beda Hartmann, Medical University of Vienna:
menorrhagia
dysfunctional uterine bleeding
endometrial ablation
cavatermTM
probe

Additional relevant MeSH terms:
Menorrhagia
Uterine Hemorrhage
Uterine Diseases
Genital Diseases, Female
Menstruation Disturbances
Pathologic Processes